Explore Pharmacology & Toxicology Webinars
Explore Pharmacology & Toxicology Webinars
Evaluation of Novel Therapies Using Spontaneous Seizure Models
Wednesday, October 4, 2023
Sponsor: ADInstruments
Partners: American Physiological Society, Society for Neuroscience, Federation of European Neuroscience Societies, American Autonomic Society, Scientist.com
In this webinar, Dr. Cameron Metcalf covers the technical requirements and benefits of spontaneous seizure models, addressing the challenges and optimization of 24/7 video-EEG data collection for epilepsy therapy development.
Turning Innovative Features Into Practical Benefits Within the Buxco Nose-Only Rodent Inhalation System
Thursday, September 28, 2023
Sponsors: Data Sciences International, Harvard Bioscience, Inc.
UV Shemesh presents Buxco’s nose-only rodent inhalation system, highlighting how it can improve research efficiency and offer valuable insights in respiratory studies.
Advancing Water Quality Monitoring: How to Easily Integrate Advanced Bioanalytical Techniques for Comprehensive Insights
Tuesday, September 26, 2023
Sponsor: INDIGO Biosciences
Partner: Scientist.com
Dr. Jack Vanden Heuvel discusses how integrating cell-based bioassays and effect-based trigger values enhances water quality assessment beyond traditional methods.
Exploring Predictive Biomarkers and ERK1/2 Phosphorylation: A New Horizon in Forecasting Survival and Response to Immune Checkpoint Blockade in Glioblastoma Treatment
Tuesday, September 26, 2023
Sponsor: Akoya Biosciences
Partner: Scientist.com
In this webinar, Victor Arrieta highlights the link between p-ERK activation and improved survival in rGBM patients using anti-PD-1 immunotherapy.
Evaluation of TruVivo, an All-Human Hepatocyte Model for Mechanistic DMPK Investigations
Tuesday, June 20, 2023
Sponsor: LifeNet Health LifeSciences
Partner: Scientist.com
Join Diane Ramsden, PhD, and Lindsey Whaley, MS, for an inside look at TruVivo™, a novel all-human in vitro hepatocyte system developed by LifeNet Health LifeSciences.
Save Time and Money When Prioritizing Drug Candidates: Using Cell-Based Reporter Assays for Nuclear Receptor Profiling
Thursday, June 1, 2023
Sponsor: INDIGO Biosciences
Dr. Jack Vanden Heuvel discusses the use of cell-based reporter assays for nuclear receptor profiling to efficiently prioritize drug candidates and minimize off-target effects.
Targeting Proteomics to Decipher Biology for the Drug Development Pipeline
Tuesday, May 16, 2023
Sponsor: Cell Signaling Technology Inc.
Partner: Scientist.com
Dr. Jeffrey Silva explores the role of mass spectrometry-based proteomics on drug discovery, disease mechanisms, and biomarker identification.
Leveraging Programmable CRISPR-Associated Transposases for Next-Generation Genome Engineering
Thursday, April 13, 2023
Sponsor: Sanguine BioSciences
Dr. Sam Sternberg discusses a novel CRISPR-Cas9 system using programmable, RNA-guided transposase, and highlights its implications for kilobase-scale genome engineering in cell and gene therapies.
APS Physiology in Disease Modeling and Drug Development Roundtable
Tuesday, January 24, 2023
Sponsor: Cytokinetics
Partner: American Physiological Society
Key opinion leaders in cardiovascular physiology and bioengineering discuss best practices and challenges when modeling cardiomyopathies and other cardiovascular diseases using stem cells, engineered tissues and other novel platforms.
The 3D DILI Model of Success – from Biological Relevance to Industry Application
Tuesday, January 24, 2023
Sponsor: InSphero
Partner: Scientist.com
Dr. Anna Borgström and Dr. Frauke Greve present the latest advancements in hepatic safety assessment using 3D liver spheroids.
Essential Bruker NMR Trainings 2023
Webinar Series
January - December 2023
On-Demand
Join Bruker experts online for 1 hour every month in this essential training program designed for NMR Scientists.
It’s Life, but Not As We Know It: How Predictive Human Organ Models Are Transforming and Reshaping the Efficiency of Drug Discovery
Tuesday, December 6, 2022
Sponsor: CN Bio
Partner: Scientist.com
Dr. Audrey Dubourg and Dr. Gareth Guenigault explore the value that an organ-on-a-chip approach can bring to drug discovery and development workflows, and how the regulatory landscape is shifting to encourage their widespread adoption.